| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,311,602 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,448,133 |
|
|
|
Indirect Value
|
$12,929,614 |
|
|
| Total
Shares |
17,986,368 |
|
|
| Total
Value |
$46,377,747 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
22
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
16
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -752.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-03 |
1,133,139 |
2024-05-03 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALVR |
Allovir Inc |
See RemarksOfficer |
• • • |
2020-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
806,607 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2008-07-10 |
4 |
S |
$75.75 |
$12,044 |
D/D |
(159) |
31,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-08-08 |
4 |
S |
$137.14 |
$37,988 |
D/D |
(277) |
178,463 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-07-10 |
4 |
S |
$36.93 |
$11,744 |
D/D |
(318) |
61,937 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-12 |
4 |
S |
$34.48 |
$12,930 |
D/D |
(375) |
59,858 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-07-16 |
4 |
S |
$38.96 |
$15,467 |
D/D |
(397) |
61,540 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-07-12 |
4 |
S |
$51.91 |
$25,228 |
D/D |
(486) |
53,821 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-03-02 |
4 |
S |
$180.34 |
$87,826 |
D/D |
(487) |
167,321 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-10 |
4 |
S |
$81.27 |
$43,236 |
D/D |
(532) |
76,749 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-19 |
4 |
S |
$47.22 |
$25,452 |
D/D |
(539) |
46,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CFO |
• – – |
2010-07-16 |
4 |
S |
$51.08 |
$27,583 |
D/D |
(540) |
53,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-01-18 |
4 |
S |
$82.66 |
$44,636 |
D/D |
(540) |
76,209 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-08-04 |
4 |
S |
$196.52 |
$132,651 |
D/D |
(675) |
166,646 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-04 |
4 |
S |
$174.37 |
$117,874 |
D/D |
(676) |
155,706 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-04 |
4 |
S |
$143.81 |
$101,116 |
D/D |
(703) |
165,943 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-01-10 |
4 |
S |
$69.02 |
$49,073 |
D/D |
(711) |
32,333 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2023-10-03 |
4 |
S |
$1.98 |
$1,492 |
D/D |
(755) |
1,172,946 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-08-05 |
4 |
S |
$116.87 |
$99,573 |
D/D |
(852) |
310,808 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-03 |
4 |
S |
$157.14 |
$133,883 |
D/D |
(852) |
132,475 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-07-27 |
4 |
AS |
$57.27 |
$49,882 |
D/D |
(871) |
352,103 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-04-02 |
4 |
S |
$0.77 |
$683 |
D/D |
(885) |
1,141,474 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-03 |
4 |
S |
$174.06 |
$155,784 |
D/D |
(895) |
156,382 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2012-07-31 |
4 |
S |
$104.94 |
$94,446 |
D/D |
(900) |
313,620 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-01-04 |
4 |
S |
$0.64 |
$614 |
D/D |
(961) |
1,166,788 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-01-29 |
4 |
S |
$94.32 |
$91,962 |
D/D |
(975) |
311,638 |
0 |
- |
|
144 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
